AZB, Cyril Amarchand Mangaldas, Hogan Lovells act on Blue Jet Healthcare ₹800 crore QIP
Blue Jet Healthcare Limited has made a qualified institutions placement of 1,58,10,276 equity shares aggregating to ₹800 crore. AZB & Partners advise Blu Jet Healthcare on this QIP. Cyril Amarchand Mangaldas advised the placement agents, Motilal Oswal Investment Advisor Limited and ICICI Securities Limited, on this QIP. The transaction was led by Ravi Dubey (Partner, Regional Co-Head - Capital Markets - West), and Oishika Dasgupta (Partner), with assistance from Abishek Sankar (Senior Associate), and Associates Akshita Dhawan, Nikshetaa Jain, Chinmay Jumde and Mitali Mangalam..
SectorPharma & Healthcare
Value₹800 cr
Sources
- Bar & Bench - Dealstreet
- BSE corporate announcements · official
- NSE corporate announcements · official
- SEBI public issues / DRHPs · official
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Cyril Amarchand Mangaldas advises Triveni Power Transmission on listing of shares post-demerger27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026